Skip to content
Bookmark Icon
Print Icon
Email Icon

Kieran Holohan's Story

Kieran Holohan

“I was treated as Kieran Holohan, not as yet another leukemia patient.”

Kieran’s Experience

"Precision medicine" is a term you hear more and more these days – even in the 2015 President's State of the Union address. Kieran Holohan is a living example of precision medicine in action. Diagnosed with Acute Myeloid leukemia (AML), he was given a 30% chance of survival, and that only after a painful and risky bone-marrow transplant. When he went to NewYork-Presbyterian, Dr. Gail Roboz took a different approach. Genetic tests revealed that Kieran's AML had a rare mutation that would let him avoid a bone transplant yet still effectively treat his leukemia. As Kieran puts it, "NewYork-Presbyterian asked the right questions. And the answers were there. They did it by throwing the playbook out the window." In January 2015, Kieran celebrated 5 years of being cancer free.

Learn about the Amazing Things happening at NewYork-Presbyterian